News – Page 997 – Endpoints News

Chinese biotech investors are pouring billions into US companies; Nektar partners with BioXcel on new I/O triple

7 years ago

FDA lifts clinical hold on Sarepta's Duchenne MD gene therapy, clearing the way to a quick launch of a pivotal trial

7 years ago

Alexion’s Soliris wows in rare disease PhIII trial, opening up a new franchise worth $500M-$700M

7 years ago

PhaseBio details dollars in AstraZeneca deal as it rolls out a plan for $86M-plus IPO

7 years ago

FDA gives Epizyme a green light on trial recruitment, but tazemetostat isn’t completely out of the woods yet

7 years ago

Trailing rivals, AstraZeneca offers a hit and a miss on key cardio study for SGLT2 diabetes drug Farxiga

7 years ago

Amarin scores a big win for its cardio outcomes study on Vascepa — stock races higher as analysts applaud

7 years ago

Ex-Cascadian chief Scott Myers lands at BioClin; Kodiak woos Genentech vet Jason Ehrlich for CMO role

7 years ago

Bayer wins OK for hemophilia A treatment; Agenus sells off a slice of future royalties for $15M

7 years ago

Parker collaborator Tessa allies with St. Jude, launches a new T cell program for pediatric brain cancer

7 years ago

Novartis drums up EU launch plans as CHMP gives thumbs up to Spark's gene therapy Luxturna

7 years ago

Giant Amgen joins a nascent effort to build a new biotech hub in LA

7 years ago

GTx execs' sole drug fails the lead indication study in a painful setback -- shares smashed

7 years ago

European regulators are locking the door on Sarepta’s Duchenne drug — but they aren’t throwing away the key

7 years ago

Fresh from the Novartis/Trump scandal, ex-CEO Joe Jimenez jumps on the board of uBiome — a biotech launching an R&D ...

7 years ago

Nasdaq parade marches on as ex-Genmab crew at Y-mAbs reaps $96M

7 years ago

Dismissing critical reports on patient deaths, FDA says safety/effectiveness of Nuplazid holds up under review

7 years ago

Brian Gallagher jumps from SR One to running the Boston office for Abingworth; Portola goes with commercial vet for ...

7 years ago

Mayo team spotlights the role of senescent cells in neurodegeneration, starting down a pathway that may lead to ...

7 years ago

Ron DePinho raises seed cash for MD Anderson colleague's work on a 'Holy Grail molecule' in cancer, inflammation

7 years ago

Drumbeat of bad news continues at OncoMed as Celgene dumps option on one of its last pipeline efforts

7 years ago

Amicus CEO Crowley bags a gene therapy company, a new pipeline — and a great photo op — for $100M in cash

7 years ago

With new $10.6B fund, Hillhouse Capital sets the stage for splashy Asia-focused biotech deals

7 years ago

Takeda blesses a little biotech's engineered toxin tech for multiple myeloma, triggering a bases loaded home run

7 years ago

First page Previous page 994 995 996997998 999 1000 Next page Last page